Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$47.98 - $54.4 $23,990 - $27,200
-500 Reduced 3.35%
14,440 $783,000
Q4 2023

Feb 08, 2024

SELL
$48.48 - $57.85 $260,773 - $311,175
-5,379 Reduced 26.47%
14,940 $766,000
Q3 2023

Nov 06, 2023

BUY
$57.89 - $64.73 $190,052 - $212,508
3,283 Added 19.27%
20,319 $1.18 Million
Q2 2023

Aug 04, 2023

BUY
$63.71 - $70.74 $22,808 - $25,324
358 Added 2.15%
17,036 $1.09 Million
Q1 2023

May 04, 2023

SELL
$65.71 - $74.53 $657,099 - $745,300
-10,000 Reduced 37.48%
16,678 $1.16 Million
Q3 2022

Nov 09, 2022

BUY
$0.13 - $76.84 $69 - $41,339
538 Added 2.06%
26,678 $1.9 Million
Q2 2022

Aug 08, 2022

SELL
$72.62 - $79.98 $220,619 - $242,979
-3,038 Reduced 10.41%
26,140 $2.01 Million
Q1 2022

May 11, 2022

SELL
$61.48 - $73.72 $614,800 - $737,200
-10,000 Reduced 25.52%
29,178 $2.13 Million
Q4 2021

Feb 04, 2022

SELL
$53.63 - $62.52 $96,909 - $112,973
-1,807 Reduced 4.41%
39,178 $2.44 Million
Q3 2021

Nov 03, 2021

SELL
$59.17 - $69.31 $260,288 - $304,894
-4,399 Reduced 9.69%
40,985 $2.43 Million
Q2 2021

Aug 03, 2021

SELL
$61.91 - $67.42 $18,573 - $20,226
-300 Reduced 0.66%
45,384 $3.03 Million
Q1 2021

Apr 19, 2021

SELL
$59.34 - $66.74 $49,192 - $55,327
-829 Reduced 1.78%
45,684 $2.88 Million
Q4 2020

Jan 25, 2021

SELL
$57.74 - $65.43 $462,612 - $524,225
-8,012 Reduced 14.69%
46,513 $3 Million
Q3 2020

Nov 10, 2020

SELL
$57.43 - $63.64 $128,758 - $142,680
-2,242 Reduced 3.95%
54,525 $3.29 Million
Q2 2020

Aug 14, 2020

BUY
$54.82 - $64.09 $1.93 Million - $2.26 Million
35,239 Added 163.69%
56,767 $3.34 Million
Q1 2020

Apr 30, 2020

SELL
$46.4 - $67.43 $37,120 - $53,944
-800 Reduced 3.58%
21,528 $1.2 Million
Q4 2019

Feb 26, 2020

BUY
$49.21 - $64.19 $47,733 - $62,264
970 Added 4.54%
22,328 $1.43 Million
Q3 2019

Nov 12, 2019

SELL
$42.77 - $50.71 $357,215 - $423,529
-8,352 Reduced 28.11%
21,358 $1.16 Million
Q2 2019

Aug 02, 2019

BUY
$44.62 - $49.34 $922,072 - $1.02 Million
20,665 Added 228.47%
29,710 $1.35 Million
Q4 2018

Feb 13, 2019

BUY
$48.76 - $63.23 $221,614 - $287,380
4,545 Added 101.0%
9,045 $470,000
Q3 2018

Nov 13, 2018

SELL
$55.19 - $62.25 $250,838 - $282,926
-4,545 Reduced 50.25%
4,500 $0
Q1 2018

May 15, 2018

BUY
$59.92 - $68.98 $541,976 - $623,924
9,045 New
9,045 $0
Q3 2017

Nov 15, 2017

SELL
$55.23 - $63.74 $384,842 - $444,140
-6,968 Closed
0 $0
Q2 2017

Aug 10, 2017

BUY
N/A
6,968
6,968 $388,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Capital Wealth Planning, LLC Portfolio

Follow Capital Wealth Planning, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Wealth Planning, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Wealth Planning, LLC with notifications on news.